Combination of losartan and puerarin induced pharmacokinetic interaction in hypertension rats enhances the antihypertensive effect of losartan

References

• Ahad A, Raish M, Bin Jardan YA, Alam MA, Al-Mohizea AM, Al-Jenoobi FI. 2020. Potential pharmacodynamic and pharmacokinetic interactions of Nigella sativa and Trigonella foenum-graecum with losartan in L-NAME induced hypertensive rats. Saudi J Biol Sci. 27(10):2544–2550.
   PubMed Web of Science ®Google Scholar
• Bondanelli M, Ambrosio MR, Degli Uberti EC. 2001. Pathogenesis and prevalence of hypertension in acromegaly. Pituitary. 4(4):239–249.
   PubMedGoogle Scholar
• Chen D, Zhang HF, Yuan TY, Sun SC, Wang RR, Wang SB, Fang LH, Lyu Y, Du GH. 2022. Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models. Acta Pharmacol Sin. 43(9):2325–2339.
   PubMed Web of Science ®Google Scholar
• Dong B, Yuan S, Hu J, Yan Y. 2018. Effects of Ginkgo leaf tablets on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol. 56(1):333–336.
   PubMed Web of Science ®Google Scholar
• Fu R, Li J, Yu H, Zhang Y, Xu Z, Martin C. 2021. The Yin and Yang of traditional Chinese and Western medicine. Med Res Rev. 41(6):3182–3200.
   PubMed Web of Science ®Google Scholar
• Guo YJ, Liang DL, Xu ZS, Ye Q. 2014. In vivo inhibitory effects of puerarin on selected rat cytochrome P450 isoenzymes. Pharmazie. 69(5):367–370.
   PubMed Web of Science ®Google Scholar
• Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O. 2020. Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol. 94(11):3671–3722.
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Yuan X, Yao D, Gao Z, Niu Z, Wang Z, Zhang Y. 2023. The effective constituent puerarin, from Pueraria lobata, inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p/IGF1 pathway. Pharm Biol. 61(1):1–11.
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Xie L, Gan D, Jiang X. 2016. Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol. 54(12):2886–2894.
   PubMed Web of Science ®Google Scholar
• Liu M, Gao Y, Yuan Y, Yang K, Shi S, Zhang J, Tian J. 2020. Efficacy and safety of integrated traditional Chinese and western medicine for corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res. 158:104896.
   PubMed Web of Science ®Google Scholar
• Lv J, Shi S, Zhang B, Xu X, Zheng H, Li Y, Cui X, Wu H, Song Q. 2022. Role of puerarin in pathological cardiac remodeling: a review. Pharmacol Res. 178:106152.
   PubMed Web of Science ®Google Scholar
• Lynch T, Price A. 2007. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 76(3):391–396.
   PubMed Web of Science ®Google Scholar
• Nagaraju B, Anilkumar KV. 2021. Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits. Indian J Pharmacol. 53(6):465–470.
   PubMed Web of Science ®Google Scholar
• Niu Z, Qiang T, Lin W, Li Y, Wang K, Wang D, Wang X. 2022. Evaluation of potential herb-drug interactions between shengmai injection and losartan potassium in rat and in vitro. Front Pharmacol. 13:878526.
   PubMed Web of Science ®Google Scholar
• Oliveras A, de la Sierra A. 2014. Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes. J Hum Hypertens. 28(4):213–217.
   PubMed Web of Science ®Google Scholar
• Park JW, Kim KA, Il Kim Y, Park JY. 2019. Pharmacokinetic and haemodynamic interactions between amlodipine and losartan in human beings. Basic Clin Pharmacol Toxicol. 125(4):345–352.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wang L, Zhao X, Lai S, He X, Fan Q, He H, He M. 2022. Puerarin attenuates lipopolysaccharide-induced myocardial injury via the 14-3-3γ/PKCε pathway activating adaptive autophagy. Int Immunopharmacol. 108:108905.
   PubMed Web of Science ®Google Scholar
• Sam NH, Nguyen LA, Hadarics M. 2021. Exploring inclusiveness towards immigrants as related to basic values: a network approach. PLoS One. 16(12):e0260624.
   PubMed Web of Science ®Google Scholar
• Shumyantseva VV, Koroleva PI, Bulko TV, Sergeev GV, Usanov SA. 2022. Predicting drug-drug interactions by electrochemically driven cytochrome P450 3A4 reactions. Drug Metab Pers Ther. 37(3):241–248.
   PubMedGoogle Scholar
• Smith BE, Madigan VM. 2018. Understanding the haemodynamics of hypertension. Curr Hypertens Rep. 20(4):29.
   PubMed Web of Science ®Google Scholar
• Tan C, Wang A, Liu C, Li Y, Shi Y, Zhou MS. 2017. Puerarin improves vascular insulin resistance and cardiovascular remodeling in salt-sensitive hypertension. Am J Chin Med. 45(6):1169–1184.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang X, Liu F, Wang M, Qin S. 2017. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism. Pharm Biol. 55(1):1863–1867.
   PubMed Web of Science ®Google Scholar
• Yang J, Li Y, Li Y, Rui X, Du M, Wang Z. 2020. Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism. Xenobiotica. 50(6):685–688.
   PubMed Web of Science ®Google Scholar
• Zhang L. 2019. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine. Drug Deliv. 26(1):860–869.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu L, Wang M. 2021. Effects of puerarin on chronic inflammation: focus on the heart, brain, and arteries. Aging Med. 4(4):317–324.
   PubMedGoogle Scholar
• Zhang Y, Lou Y, Wang J, Yu C, Shen W. 2020. Research status and molecular mechanism of the traditional chinese medicine and antitumor therapy combined strategy based on tumor microenvironment. Front Immunol. 11:609705.
   PubMed Web of Science ®Google Scholar
• Zhong LL, Zheng Y, Lau AY, Wong N, Yao L, Wu X, Shao T, Lu Z, Li H, Yuen CS, et al. 2022. Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis. Stroke Vasc Neurol. 7(1):77–85.
   PubMedGoogle Scholar
• Zhou T, Wang Z, Guo M, Zhang K, Geng L, Mao A, Yang Y, Yu F. 2020. Puerarin induces mouse mesenteric vasodilation and ameliorates hypertension involving endothelial TRPV4 channels. Food Funct. 11(11):10137–10148.
   PubMed Web of Science ®Google Scholar
• Zhou YX, Zhang H, Peng C. 2014. Puerarin: a review of pharmacological effects. Phytother Res. 28(7):961–975.
   PubMed Web of Science ®Google Scholar
• Zhou YX, Zhang H, Peng C. 2021. Effects of puerarin on the prevention and treatment of cardiovascular diseases. Front Pharmacol. 12:771793.
   PubMed Web of Science ®Google Scholar